Malaria is one of the world’s leading health problems, and particularly affects young children and pregnant women. While substantial progress has been made in reducing the global burden in the past decade, progress has stalled in recent years with a number of major challenges.
There is an urgent need for effective vaccines, new drugs to treat the disease, new prevention strategies, and improvements in diagnosis and surveillance. Plasmodium falciparum, causes most clinical cases and deaths globally, however P. vivax also causes a high burden of disease in Asia and Pacific region.
Our research centres on five different approaches:
- Immunity to malaria in humans
- Vaccines against malaria
- Mechanisms of infection
- Malaria surveillance
- Clinical and operational research on malaria.
In addition, we apply our research to the Burnet Institute Healthy Mothers, Healthy Babies program in Papua New Guinea, which is a collaborative research program aimed at providing life-saving health care for women and children in PNG.
Hear more from Malaria Immunity and Vaccines Group Head, Professor James Beeson and discover more about Burnet's malaria work in Episode 8 of our How Science Matters podcast.
is a collaborative research program aimed at providing life-saving health care for women and children in PNG.
Working
Group
Meet the working group. Together, we are translating research into better health, for all.
Projects
